Mond James 4
4 · ADMA BIOLOGICS, INC. · Filed Nov 20, 2012
Insider Transaction Report
Form 4
Mond James
CSO/CMO
Transactions
- Award
Options to purchase
2012-11-19+106,067→ 106,067 totalExercise: $9.60Exp: 2022-07-18→ Common Stock (106,067 underlying)
Footnotes (1)
- [F1]These options, granted pursuant to the issuer's 2007 Stock Option Plan (the "Plan") vest over four years with 25% vesting on July 18, 2013, and the remaining 75% vesting in equal monthly installments over the next 36 months. The options were granted in July 2012, but the grant remained subject to approval by the stockholders of the issuer of an amendment to the Plan to increase the number of shares of common stock subject to the Plan from 561,000 to 711,200. Stockholder approval was obtained by means of a written consent and the issuer filed a related Information Statement on Schedule 14-C with the SEC on October 29, 2012. The amendment to the Plan became effective on November 19, 2012.